Genetic origin of Dupuytren*s disease and associated fibromatosis
- Conditions
- Dupuytren's diseaseLedderhose's diseasePeyronie's disease1002839610010761
- Registration Number
- NL-OMON30567
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 600
Gene expression study:
1.Clinically confirmed diagnosis of Dupuytren*s, Peyronie*s or Ledderhose*s disease
2.Patient for which selective fasciectomy or plaque excision/biopsy is part of standard treatment
3.Evident cord AND node at physical examination (only for patients with Dupuytren*s disease)
4. Age >= 18;Gene expression study Dupuytren controls:
1.Confirmed diagnosis of Carpal Tunnel Syndrome
2.Patient for which carpal tunnel release is part of standard treatment
3.Age >= 18;Gene expression study Peyronie controls:
1.Patient receiving penile prosthesis implants for erectile dysfunction or patient having penis amputation
2.Age >= 18;Pedigree analysis and association study:
1.Clinically confirmed diagnosis of Dupuytren*s disease, Peyronie*s disease or Ledderhose*s disease
2.Having relatives with one of these diseases (only for pedigree analysis)
3.Age >= 18;Pedigree analysis family of proband:
1. Age >= 18;Association study controls:
1.Age >= 18
Gene expression study:
1.Post-surgical recurrence
2.Patients unfit to undergo surgery;Gene expression study Dupuytren controls:
1.Diagnosis of Dupuytren*s, Peyronie*s or Ledderhose*s disease or a positive family history for one of these diseases;Gene expression study Peyronie controls:
1.Diagnosis of Dupuytren*s, Peyronie*s or Ledderhose*s disease or a positive family history for one of these diseases;Pedigree analysis and association study:
None;Pedigree analysis family of proband:
None;Association study controls:
1.Diagnosis of Dupuytren*s disease, Peyronie*s disease or Ledderhose*s disease or a positive family history for one of these diseases
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Finding the causative gene(s) of the different fibromatosis. Increasing<br /><br>understanding of the etiology/pathology of the diseases and there relation to<br /><br>each other. </p><br>
- Secondary Outcome Measures
Name Time Method <p>...</p><br>